Intellipharmaceutics submits new drug application for Rexista
Saturday, November 26, 2016
Intellipharmaceutics submits new drug application for Rexista(oxycodone hydrochloride extended release), an abuse deterrent opioid analgesic for the treatment of moderate to severe pain.
Intellipharmaceutics International - Has identified potential manufacturing partners; currently evaluating manufacturing options for Rexista in U.S.
Source : reuters.com
